Literature DB >> 26594387

A monoclinic polymorph of 4-(2H-1,3-benzodioxol-5-yl)-1-(4-methyl-phen-yl)-1H-pyrazol-5-amine.

Mukesh M Jotani1, Nilesh N Gajera2, Mukesh C Patel2, Herman H Y Sung3, Edward R T Tiekink4.   

Abstract

The title compound, n class="Chemical">C17H15N3O2, is a moclass="Chemical">nocliclass="Chemical">nic polymorph (P21/c with Z' = 1) of the previously reported tricliclass="Chemical">nic (P-1 with Z' = 2) form [Gajera et al. (2013 ▸). Acta Cryst. E69, o736-o737]. The mol-ecule iclass="Chemical">n the moclass="Chemical">nocliclass="Chemical">nic polymorph features a ceclass="Chemical">ntral class="Chemical">n class="Chemical">pyrazolyl ring with an N-bound p-tolyl group and a C-bound 1,3-benzodioxolyl fused-ring system on either side of the C atom bearing the amino group. The dihedral angles between the central ring and the N- and C-bound rings are 50.06 (5) and 27.27 (5)°, respectively. The angle between the pendent rings is 77.31 (4)°, indicating the mol-ecule has a twisted conformation. The five-membered dioxolyl ring has an envelope conformation with the methyl-ene C atom being the flap. The relative disposition of the amino and dioxolyl substituents is syn. One of the independent mol-ecules in the triclinic form has a similar syn disposition but the other has an anti arrangement of these substituents. In the crystal structure of the monoclinic form, mol-ecules assemble into supra-molecular helical chains via amino-pyrazolyl N-H⋯N hydrogen bonds. These are linked into layers via C-H⋯π inter-actions, and layers stack along the a axis with no specific inter-actions between them.

Entities:  

Keywords:  Hirshfeld surface; amine; conformation; crystal structure; polymorph

Year:  2015        PMID: 26594387      PMCID: PMC4647416          DOI: 10.1107/S2056989015016023

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Chemical context

It is the broad range of biological activities, such as anti-depressant, anti-n class="Disease">anxiety, aclass="Chemical">nti-fuclass="Chemical">ngal, aclass="Chemical">nti-bacterial, aclass="Chemical">nti-class="Chemical">n class="Disease">diabetic, anti-cancer, etc. (Tanitame et al., 2004 ▸; Chimenti et al., 2006 ▸; Ding et al.,2009 ▸; Shen et al., 2011 ▸; Deng et al., 2012 ▸), that continues to inspire inter­est in compounds containing the amino-substituted pyrazole unit. It was in this context that the crystal structure of 4-(2H-1,3-benzodioxol-5-yl)-1-(4-methyl­phen­yl)-1H-pyrazol-5-amine (I) was originally determined (Gajera et al., 2013 ▸). Subsequently, during scale up, crystals of the monoclinic form were isolated from recrystallization of (I) from ethyl acetate, the same solvent system that afforded the original triclinic polymorph. Herein, the crystal and mol­ecular structures of the monoclinic form of (I), hereafter (mI), are described and compared with the triclinic polymorph, (tI).

Structural commentary

The mol­ecule in (n class="Chemical">mI), Fig. 1 ▸, comprises a ceclass="Chemical">ntral aclass="Chemical">nd almost placlass="Chemical">nar class="Chemical">n class="Chemical">pyrazolyl ring (r.m.s. deviation of the five atoms = 0.0043 Å) flanked by an N-bound p-tolyl group and a C-bound 1,3-benzodioxolyl fused ring system. In the latter, the five-membered dioxolyl ring adopts an envelope conformation with the methyl­ene-C17 atom being the flap; the C17 atom lies 0.318 (2) Å out of the least-squares plane defined by the O1, O2, C14 and C15 atoms (r.m.s. deviation = 0.0005 Å). The dihedral angles between the central ring and the N- and C-bound six-membered rings are 50.06 (5) and 27.27 (5)°, respectively. The dihedral angle between the six-membered rings is 77.31 (4)°, indicating an overall twisted arrangement. In general terms, the relative disposition of the amino and dioxolyl substituents may be described as being syn.
Figure 1

The mol­ecular structure of the mol­ecule found in the monoclinic polymorph showing the atom-labelling scheme and displacement ellipsoids at the 70% probability level.

While (n class="Chemical">mI) crystallizes with Z′ = 1, the tricliclass="Chemical">nic polymorph, (tI), crystallizes with Z′ = 2 (Gajera et al., 2013 ▸). Iclass="Chemical">n the latter, the mol­ecules have quite differeclass="Chemical">nt coclass="Chemical">nformatioclass="Chemical">ns. Iclass="Chemical">n oclass="Chemical">ne of the iclass="Chemical">ndepeclass="Chemical">ndeclass="Chemical">nt mol­ecules, the aclass="Chemical">n class="Chemical">mino and dioxolyl substit­uents are syn, as for (mI), and in the other these substituents are anti. These differences in mol­ecular conformations are highlighted in Fig. 2 ▸. The syn/anti distinction is quite clear from this overlap diagram where the dioxolyl ring obviously occupies a different position in the second independent mol­ecule of (tI, blue image). Also evident from Fig. 2 ▸ are variations in the relative dispositions of six-membered rings. These variations are qu­anti­fied in Table 1 ▸.
Figure 2

Overlay diagram of the title compound, (mI), red image, with the two independent mol­ecules in (tI), green (mol­ecule a) and blue (b) images. The mol­ecules have been overlapped so that the central pyrazolyl rings are coincident.

Table 1

Dihedral angle () data for the three independent molecules in (mI) and (tI)

Structurepyrazolyl/p-tolylpyrazolyl/benzo-C6 p-tolyl/benzo-C6
(mI)50.06(5)27.27(5)77.31(4)
(tI), molecule a 49.08(9)47.18(7)85.22(8)
(tI), molecule b 68.22(9)31.67(8)80.63(8)

PXRD study

In order to ascertain the nature of the crystalline residue isolated from recrystallization of (I) from n class="Chemical">ethyl acetate solutioclass="Chemical">n, a powder X-ray diffractioclass="Chemical">n (PXRD) experimeclass="Chemical">nt was performed oclass="Chemical">n a PAclass="Chemical">n class="Chemical">Nalytical Empyrean XRD system with Cu Kα1 radiation (λ = 1.54056 Å) in the 2θ range of 5 to 50° with a step size of 0.026°. The pattern was analyzed with X’Pert HighScore Plus (PANalytical, 2009 ▸). This analysis indicated that the ratio of (mI) to (tI) in the overall sample was 49.1:50.9. This distribution suggests that effectively in the sample there is a 3:1 ratio of mol­ecules with a syn disposition of the amino and dioxolyl substituents to those with a trans arrangement.

Supra­molecular features

The most notable feature of the crystal packing in (n class="Chemical">mI) is the formatioclass="Chemical">n of supra­molecular helical chaiclass="Chemical">ns aligclass="Chemical">ned aloclass="Chemical">ng the b axis aclass="Chemical">nd mediated by aclass="Chemical">n class="Chemical">mino–pyrazolyl N—H⋯N hydrogen bonds, Fig. 3 ▸ and Table 2 ▸. The chains are consolidated into layers in the bc plane by pyrazol­yl–tolyl C10—H⋯π and methyl­ene–benzo-C6 C17—H⋯π inter­actions, Table 2 ▸. The layers inter-digitate along the a axis whereby the dioxolyl rings face each other, Fig. 4 ▸. The C—H⋯O inter­actions are at distances beyond the standard criteria (Spek, 2009 ▸). In the packing scheme just described, no specific role is found for the second amino-H2N atom. To a first approximation, the mode of association between mol­ecules in (tI) is similar in that supra­molecular chains are formed. These comprise alternating independent mol­ecules a and b that are connected by amino–pyrazolyl N—H⋯N hydrogen bonds. The difference is that in (tI), the chains have a zigzag topology. Chains in (tI) are connected by C—H⋯O and C—H⋯π inter­actions.
Figure 3

A view of a supra­molecular helical chain aligned along the b axis and mediated by amino–pyrazolyl N—H⋯N hydrogen bonds shown as blue dashed lines.

Table 2

Hydrogen-bond geometry (, )

Cg1 and Cg2 are the centroids of the C2C7 and C11C16 rings, respectively.

DHA DHHA D A DHA
N3H1NN2i 0.88(2)2.16(2)2.9981(16)159(1)
C10H10Cg1ii 0.952.973.6753(14)133
C17H17B Cg2iii 0.992.663.6334(15)169

Symmetry codes: (i) ; (ii) ; (iii) .

Figure 4

Unit-cell contents shown in projection down the c axis. The N—H⋯N and C—H⋯π inter­actions are shown as blue and purple dashed lines, respectively.

Analysis of the Hirshfeld surfaces

In order to investigate further the nature of the crystal packing in (n class="Chemical">mI) aclass="Chemical">nd (tI), aclass="Chemical">n aclass="Chemical">nalysis of the Hirshfeld surfaces (Spackmaclass="Chemical">n & Jayatilaka, 2009 ▸) was uclass="Chemical">ndertakeclass="Chemical">n employiclass="Chemical">ng CrystalExplorer (Wolff et al., 2012 ▸). The Hirshfeld surfaces were mapped over d class="Chemical">norm for each of the three mol­ecules, Fig. 5 ▸. The poiclass="Chemical">nts of coclass="Chemical">ntact correspoclass="Chemical">ndiclass="Chemical">ng to the aclass="Chemical">n class="Chemical">mino–pyrazolyl N—H⋯N hydrogen bonds are recognized easily by deep-red depressions on the Hirshfeld surfaces of all three mol­ecules. The C—H⋯π inter­actions in (mI) are indicated by both diminutive spots and light-red regions on the surface. These are also apparent in (tI) with additional features arising from the C—H⋯O contacts, Fig. 5 ▸. The fingerprint plots (Rohl et al., 2008 ▸) were also calculated and enabled a delineation of the relative contribution of the different inter­molecular contacts to the respective crystal structures. These contributions are illustrated graphically in Fig. 6 ▸. Despite the different modes of association between the respective mol­ecules, to a first approximation the relative contributions to the surfaces are similar.
Figure 5

Views of the Hirshfeld surfaces for (a) (mI), (b) (tI) – mol­ecule a, and (c) (tI) – mol­ecule b.

Figure 6

Relative contributions of various inter­molecular contacts to the Hirshfeld surface area in (a) mI, and of (tI) mol­ecules (b) a and (c) b.

Database survey

A search of the Cambridge Structural Database (Groom & Allen, 2014 ▸), revealed there are no direct analogues of (I), i.e. 1,3 n class="Chemical">N- aclass="Chemical">nd C-disubstituted species. There are four examples of 1,3,4 tris­ubstituted aclass="Chemical">nalogues (Abu Thaher et al., 2012 ▸; aclass="Chemical">nd refereclass="Chemical">nces thereiclass="Chemical">n).

Synthesis and crystallization

The title compound was synthesized according to the same synthetic process as described in the original report (Gajera et al., 2013 ▸). Single crystals suitable for X-ray measurements in the form of light-brown prisms were obtained from its n class="Chemical">ethyl acetate solutioclass="Chemical">n at room temperature.

Refinement

Crystal data, data collection and structure refinement details are summarized in Table 3 ▸. n class="Chemical">Carbon-bouclass="Chemical">nd class="Chemical">n class="Disease">H-atoms were placed in calculated positions (C—H = 0.95–0.99 Å) and were included in the refinement in the riding model approximation, with U iso(H) set to 1.2–1.5U eq(C). The N-bound H atoms were located in a difference Fourier map but were refined with a distance restraint of N—H = 0.88±0.01 Å, and with U iso(H) set to 1.2U eq(N).
Table 3

Experimental details

Crystal data
Chemical formulaC17H15N3O2
M r 293.32
Crystal system, space groupMonoclinic, P21/c
Temperature (K)100
a, b, c ()13.9652(3), 10.6898(2), 9.8459(2)
()109.844(2)
V (3)1382.57(5)
Z 4
Radiation typeCu K
(mm1)0.77
Crystal size (mm)0.35 0.25 0.15
 
Data collection
DiffractometerAgilent SuperNova Dual diffractometer with an Atlas detector
Absorption correctionMulti-scan (CrysAlis PRO; Agilent, 2014)
T min, T max 0.989, 1.000
No. of measured, independent and observed [I > 2(I)] reflections4379, 2582, 2289
R int 0.013
(sin /)max (1)0.609
 
Refinement
R[F 2 > 2(F 2)], wR(F 2), S 0.036, 0.096, 1.03
No. of reflections2582
No. of parameters206
No. of restraints2
H-atom treatmentH atoms treated by a mixture of independent and constrained refinement
max, min (e 3)0.19, 0.27

Computer programs: CrysAlis PRO (Agilent, 2014 ▸), SHELXL97 (Sheldrick, 2008 ▸), SHELXL2014 (Sheldrick, 2015 ▸), ORTEP-3 for Windows (Farrugia, 2012 ▸), QMol (Gans Shalloway, 2001 ▸), DIAMOND (Brandenburg, 2006 ▸) and publCIF (Westrip, 2010 ▸).

Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S2056989015016023/hb7490sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015016023/hb7490Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989015016023/hb7490Isup3.cml CCDC reference: 1420783 Additional supporting information: crystallographic information; 3D view; checkCIF report
C17H15N3O2F(000) = 616
Mr = 293.32Dx = 1.409 Mg m3
Monoclinic, P21/cCu Kα radiation, λ = 1.54184 Å
a = 13.9652 (3) ÅCell parameters from 2900 reflections
b = 10.6898 (2) Åθ = 5.3–75.6°
c = 9.8459 (2) ŵ = 0.77 mm1
β = 109.844 (2)°T = 100 K
V = 1382.57 (5) Å3Prism, light-brown
Z = 40.35 × 0.25 × 0.15 mm
Agilent SuperNova Dual diffractometer with an Atlas detector2582 independent reflections
Radiation source: SuperNova (Cu) X-ray Source2289 reflections with I > 2σ(I)
Mirror monochromatorRint = 0.013
ω scansθmax = 70.0°, θmin = 5.3°
Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2014)h = −16→12
Tmin = 0.989, Tmax = 1.000k = −12→12
4379 measured reflectionsl = −11→11
Refinement on F22 restraints
Least-squares matrix: fullHydrogen site location: mixed
R[F2 > 2σ(F2)] = 0.036H atoms treated by a mixture of independent and constrained refinement
wR(F2) = 0.096w = 1/[σ2(Fo2) + (0.0527P)2 + 0.5203P] where P = (Fo2 + 2Fc2)/3
S = 1.03(Δ/σ)max < 0.001
2582 reflectionsΔρmax = 0.19 e Å3
206 parametersΔρmin = −0.27 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
xyzUiso*/Ueq
O1−0.01538 (7)0.79537 (9)0.05812 (10)0.0229 (2)
O20.09248 (7)0.63677 (9)0.17958 (10)0.0229 (2)
N10.47346 (8)0.93081 (10)0.71284 (11)0.0146 (2)
N20.46867 (8)1.04737 (10)0.65038 (11)0.0168 (2)
N30.38155 (8)0.73744 (11)0.67648 (13)0.0229 (3)
H1N0.4302 (10)0.6978 (15)0.7442 (15)0.028*
H2N0.3203 (8)0.7054 (15)0.6459 (17)0.028*
C10.79815 (10)0.85389 (13)1.24901 (15)0.0226 (3)
H1A0.79640.92211.31470.034*
H1B0.86370.85471.23300.034*
H1C0.78960.77371.29170.034*
C20.71312 (10)0.87116 (12)1.10672 (14)0.0178 (3)
C30.73229 (9)0.91569 (12)0.98529 (14)0.0188 (3)
H30.80020.93470.99190.023*
C40.65366 (9)0.93269 (12)0.85479 (14)0.0173 (3)
H40.66790.96270.77280.021*
C50.55400 (9)0.90549 (11)0.84473 (13)0.0146 (3)
C60.53312 (9)0.86113 (11)0.96412 (13)0.0161 (3)
H60.46510.84270.95740.019*
C70.61276 (10)0.84398 (12)1.09371 (14)0.0174 (3)
H70.59840.81301.17520.021*
C80.39184 (9)0.85823 (12)0.63961 (13)0.0149 (3)
C90.33011 (9)0.93033 (12)0.52569 (13)0.0154 (3)
C100.38242 (10)1.04516 (12)0.54044 (13)0.0170 (3)
H100.35791.11410.47730.020*
C110.23592 (9)0.89631 (12)0.40828 (13)0.0157 (3)
C120.16893 (9)0.99103 (12)0.33479 (14)0.0180 (3)
H120.18281.07470.36830.022*
C130.08223 (10)0.96750 (13)0.21382 (14)0.0199 (3)
H130.03791.03280.16460.024*
C140.06491 (9)0.84515 (13)0.17031 (13)0.0177 (3)
C150.12917 (9)0.75009 (12)0.24281 (14)0.0170 (3)
C160.21486 (9)0.77116 (12)0.36133 (14)0.0169 (3)
H160.25800.70440.40950.020*
C170.01608 (10)0.66946 (14)0.04489 (14)0.0217 (3)
H17A−0.04270.61180.02370.026*
H17B0.04420.6637−0.03470.026*
U11U22U33U12U13U23
O10.0172 (4)0.0250 (5)0.0207 (5)0.0016 (4)−0.0013 (4)−0.0017 (4)
O20.0204 (5)0.0185 (5)0.0223 (5)−0.0015 (4)−0.0023 (4)−0.0026 (4)
N10.0150 (5)0.0125 (5)0.0151 (5)−0.0002 (4)0.0036 (4)0.0007 (4)
N20.0198 (5)0.0137 (5)0.0161 (5)−0.0013 (4)0.0050 (4)0.0010 (4)
N30.0144 (5)0.0165 (6)0.0307 (7)−0.0019 (4)−0.0017 (5)0.0071 (5)
C10.0221 (7)0.0219 (7)0.0195 (7)−0.0008 (5)0.0015 (5)0.0003 (5)
C20.0197 (6)0.0134 (6)0.0178 (6)0.0013 (5)0.0030 (5)−0.0025 (5)
C30.0148 (6)0.0188 (6)0.0217 (7)−0.0007 (5)0.0046 (5)−0.0014 (5)
C40.0183 (6)0.0170 (6)0.0171 (6)0.0000 (5)0.0066 (5)−0.0001 (5)
C50.0158 (6)0.0116 (6)0.0147 (6)0.0013 (4)0.0031 (5)−0.0023 (5)
C60.0153 (6)0.0142 (6)0.0189 (6)0.0003 (5)0.0061 (5)−0.0016 (5)
C70.0223 (6)0.0141 (6)0.0162 (6)0.0009 (5)0.0071 (5)−0.0008 (5)
C80.0127 (6)0.0154 (6)0.0171 (6)−0.0001 (4)0.0057 (5)−0.0013 (5)
C90.0153 (6)0.0147 (6)0.0160 (6)0.0009 (5)0.0052 (5)0.0005 (5)
C100.0199 (6)0.0150 (6)0.0149 (6)0.0002 (5)0.0046 (5)0.0014 (5)
C110.0141 (6)0.0182 (6)0.0157 (6)−0.0001 (5)0.0062 (5)0.0017 (5)
C120.0179 (6)0.0157 (6)0.0202 (6)0.0011 (5)0.0063 (5)0.0011 (5)
C130.0178 (6)0.0198 (7)0.0204 (7)0.0045 (5)0.0045 (5)0.0046 (5)
C140.0132 (6)0.0238 (7)0.0143 (6)0.0002 (5)0.0026 (5)0.0015 (5)
C150.0160 (6)0.0166 (6)0.0183 (6)−0.0010 (5)0.0057 (5)−0.0003 (5)
C160.0141 (6)0.0171 (6)0.0181 (6)0.0016 (5)0.0035 (5)0.0025 (5)
C170.0180 (6)0.0242 (7)0.0190 (6)−0.0007 (5)0.0013 (5)−0.0026 (5)
O2—C151.3787 (16)C4—H40.9500
O2—C171.4347 (15)C5—C61.3872 (18)
O1—C141.3856 (15)C6—C71.3911 (17)
O1—C171.4354 (17)C6—H60.9500
N1—C81.3649 (16)C7—H70.9500
N1—N21.3810 (15)C8—C91.3925 (17)
N1—C51.4258 (15)C9—C101.4105 (17)
N2—C101.3183 (16)C9—C111.4719 (17)
N3—C81.3621 (17)C10—H100.9500
N3—H1N0.883 (9)C11—C121.4016 (18)
N3—H2N0.875 (9)C11—C161.4134 (18)
C1—C21.5091 (17)C12—C131.4032 (17)
C1—H1A0.9800C12—H120.9500
C1—H1B0.9800C13—C141.372 (2)
C1—H1C0.9800C13—H130.9500
C2—C71.3940 (19)C14—C151.3830 (18)
C2—C31.3946 (19)C15—C161.3771 (17)
C3—C41.3898 (17)C16—H160.9500
C3—H30.9500C17—H17A0.9900
C4—C51.3921 (18)C17—H17B0.9900
C15—O2—C17104.43 (10)N3—C8—N1122.88 (11)
C14—O1—C17104.05 (9)N3—C8—C9130.31 (12)
C8—N1—N2111.85 (10)N1—C8—C9106.77 (11)
C8—N1—C5129.22 (11)C8—C9—C10103.96 (11)
N2—N1—C5118.74 (10)C8—C9—C11129.77 (12)
C10—N2—N1104.01 (10)C10—C9—C11126.12 (11)
C8—N3—H1N122.2 (11)N2—C10—C9113.40 (11)
C8—N3—H2N117.3 (11)N2—C10—H10123.3
H1N—N3—H2N119.0 (16)C9—C10—H10123.3
C2—C1—H1A109.5C12—C11—C16119.12 (12)
C2—C1—H1B109.5C12—C11—C9119.26 (12)
H1A—C1—H1B109.5C16—C11—C9121.47 (11)
C2—C1—H1C109.5C11—C12—C13122.76 (12)
H1A—C1—H1C109.5C11—C12—H12118.6
H1B—C1—H1C109.5C13—C12—H12118.6
C7—C2—C3118.16 (12)C14—C13—C12116.48 (12)
C7—C2—C1120.64 (12)C14—C13—H13121.8
C3—C2—C1121.20 (12)C12—C13—H13121.8
C4—C3—C2121.06 (12)C13—C14—C15121.64 (12)
C4—C3—H3119.5C13—C14—O1128.63 (12)
C2—C3—H3119.5C15—C14—O1109.69 (12)
C3—C4—C5119.71 (12)C16—C15—O2127.53 (12)
C3—C4—H4120.1C16—C15—C14122.83 (12)
C5—C4—H4120.1O2—C15—C14109.63 (11)
C6—C5—C4120.25 (11)C15—C16—C11117.16 (11)
C6—C5—N1120.59 (11)C15—C16—H16121.4
C4—C5—N1119.06 (11)C11—C16—H16121.4
C5—C6—C7119.32 (11)O2—C17—O1107.40 (10)
C5—C6—H6120.3O2—C17—H17A110.2
C7—C6—H6120.3O1—C17—H17A110.2
C6—C7—C2121.51 (12)O2—C17—H17B110.2
C6—C7—H7119.2O1—C17—H17B110.2
C2—C7—H7119.2H17A—C17—H17B108.5
C8—N1—N2—C101.15 (13)C8—C9—C10—N20.51 (14)
C5—N1—N2—C10−174.21 (10)C11—C9—C10—N2−175.48 (11)
C7—C2—C3—C40.04 (19)C8—C9—C11—C12158.82 (13)
C1—C2—C3—C4−179.34 (12)C10—C9—C11—C12−26.24 (19)
C2—C3—C4—C50.3 (2)C8—C9—C11—C16−25.6 (2)
C3—C4—C5—C6−0.26 (19)C10—C9—C11—C16149.34 (13)
C3—C4—C5—N1176.08 (11)C16—C11—C12—C13−1.36 (19)
C8—N1—C5—C6−47.97 (18)C9—C11—C12—C13174.33 (11)
N2—N1—C5—C6126.47 (12)C11—C12—C13—C140.57 (19)
C8—N1—C5—C4135.70 (13)C12—C13—C14—C150.53 (19)
N2—N1—C5—C4−49.86 (16)C12—C13—C14—O1178.07 (12)
C4—C5—C6—C7−0.10 (18)C17—O1—C14—C13168.94 (14)
N1—C5—C6—C7−176.39 (11)C17—O1—C14—C15−13.28 (14)
C5—C6—C7—C20.44 (19)C17—O2—C15—C16−168.01 (13)
C3—C2—C7—C6−0.41 (19)C17—O2—C15—C1413.12 (14)
C1—C2—C7—C6178.98 (12)C13—C14—C15—C16−0.8 (2)
N2—N1—C8—N3177.01 (11)O1—C14—C15—C16−178.81 (11)
C5—N1—C8—N3−8.2 (2)C13—C14—C15—O2178.09 (12)
N2—N1—C8—C9−0.87 (14)O1—C14—C15—O20.12 (15)
C5—N1—C8—C9173.88 (11)O2—C15—C16—C11−178.70 (12)
N3—C8—C9—C10−177.44 (13)C14—C15—C16—C110.03 (19)
N1—C8—C9—C100.23 (13)C12—C11—C16—C151.02 (18)
N3—C8—C9—C11−1.7 (2)C9—C11—C16—C15−174.57 (11)
N1—C8—C9—C11176.01 (12)C15—O2—C17—O1−21.31 (13)
N1—N2—C10—C9−1.00 (14)C14—O1—C17—O221.29 (13)
D—H···AD—HH···AD···AD—H···A
N3—H1N···N2i0.88 (2)2.16 (2)2.9981 (16)159 (1)
C10—H10···Cg1ii0.952.973.6753 (14)133
C17—H17B···Cg2iii0.992.663.6334 (15)169
  12 in total

1.  Qmol: a program for molecular visualization on Windows-based PCs.

Authors:  J D Gans; D Shalloway
Journal:  J Mol Graph Model       Date:  2001       Impact factor: 2.518

2.  Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core.

Authors:  Dong-Ming Shen; Edward J Brady; Mari R Candelore; Qing Dallas-Yang; Victor D-H Ding; William P Feeney; Guoquiang Jiang; Margaret E McCann; Steve Mock; Sajjad A Qureshi; Richard Saperstein; Xiaolan Shen; Xinchun Tong; Laurie M Tota; Michael J Wright; Xiaodong Yang; Song Zheng; Kevin T Chapman; Bei B Zhang; James R Tata; Emma R Parmee
Journal:  Bioorg Med Chem Lett       Date:  2010-11-21       Impact factor: 2.823

3.  Synthesis and in vitro antifungal evaluation of 1,3,5-trisubstituted-2-pyrazoline derivatives.

Authors:  Hui Deng; Zhi-Yi Yu; Guan-Ying Shi; Ming-Jing Chen; Ke Tao; Tai-Ping Hou
Journal:  Chem Biol Drug Des       Date:  2012-03       Impact factor: 2.817

Review 4.  Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase A inhibitors.

Authors:  Franco Chimenti; Adriana Bolasco; Fedele Manna; Daniela Secci; Paola Chimenti; Arianna Granese; Olivia Befani; Paola Turini; Roberto Cirilli; Francesco La Torre; Stefano Alcaro; Francesco Ortuso; Thierry Langer
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

5.  Synthesis of novel pyrazole carboxamide derivatives and discovery of modulators for apoptosis or autophagy in A549 lung cancer cells.

Authors:  Xiao-Ling Ding; Hai-Yan Zhang; Lei Qi; Bao-Xiang Zhao; Song Lian; Hong-Shui Lv; Jun-Ying Miao
Journal:  Bioorg Med Chem Lett       Date:  2009-08-03       Impact factor: 2.823

6.  Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives.

Authors:  Akihiko Tanitame; Yoshihiro Oyamada; Keiko Ofuji; Mika Fujimoto; Noritaka Iwai; Yoichi Hiyama; Kenji Suzuki; Hideaki Ito; Hideo Terauchi; Motoji Kawasaki; Kazuo Nagai; Masaaki Wachi; Jun-ichi Yamagishi
Journal:  J Med Chem       Date:  2004-07-01       Impact factor: 7.446

7.  Crystal structure refinement with SHELXL.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr C Struct Chem       Date:  2015-01-01       Impact factor: 1.172

8.  4-(2H-1,3-Benzodioxol-5-yl)-1-(4-methyl-phenyl)-1H-pyrazol-5-amine.

Authors:  Nilesh N Gajera; Mukesh C Patel; Mukesh M Jotani; Edward R T Tiekink
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-04-17

9.  4-(4-Fluoro-phen-yl)-3-(pyridin-4-yl)-1-(2,4,6-trichloro-phen-yl)-1H-pyrazol-5-amine.

Authors:  Bassam Abu Thaher; Pierre Koch; Dieter Schollmeyer; Stefan Laufer
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-08-01

10.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.